Document Detail


Comparative imipenem treatment of Staphylococcus aureus endocarditis in the rat.
MedLine Citation:
PMID:  6583198     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The efficacy of imipenem alone or in association with gentamicin against Staphylococcus aureus experimental endocarditis was compared to the efficacy of cloxacillin alone or in association with gentamicin. Parenteral treatment was started 24 h after intravenous bacterial challenge of rats with catheter-induced aortic valve vegetations. The cloxacillin MIC and MBC for Staph. aureus were 0.125 and 32 mg/l and the imipenem MIC and MBC 0.008 and 8 mg/l, respectively. In-vitro killing curves showed a synergistic effect between cloxacillin and gentamicin, and an additive effect between imipenem and gentamicin. Only large doses of cloxacillin (400 mg/kg tid) (producing serum levels above those obtained after intravenous injection of 2 g in man) achieved results comparable to those of imipenem 80 mg/kg tid (producing serum levels similar to those obtained after an intravenous dose of 750 mg in man) in reducing the bacterial numbers in vegetations after 3 and 5 days of treatment. There was a significantly greater reduction of bacterial numbers in vegetations after treatment with the association of cloxacillin and gentamicin than with cloxacillin alone. In contrast, the addition of gentamicin to imipenem did not improve significantly the results of treatment with imipenem alone, but imipenem alone was as good as the combination cloxacillin and gentamicin after 5 days of treatment. We conclude that imipenem is a highly bactericidal drug in this animal model, worth considering for clinical trials in the treatment of Staph. aureus infections.
Authors:
J D Baumgartner; M P Glauser
Related Documents :
22971188 - Influence of the quantity of sunscreen applied on the ability to protect against ultrav...
18716688 - A pilot study to compare tobramycin 80 mg injectable preparation with 300 mg solution f...
7143688 - Wide interpatient variations in gentamicin dose requirements for geriatric patients.
11783768 - Pharmacokinetics of intraperitoneal cefazolin and gentamicin in empiric therapy of peri...
19947898 - Quercetin supplementation does not alter antioxidant status in humans.
22801398 - Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients w...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  The Journal of antimicrobial chemotherapy     Volume:  12 Suppl D     ISSN:  0305-7453     ISO Abbreviation:  J. Antimicrob. Chemother.     Publication Date:  1983 Dec 
Date Detail:
Created Date:  1984-04-11     Completed Date:  1984-04-11     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7513617     Medline TA:  J Antimicrob Chemother     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  79-87     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cloxacillin / therapeutic use*
Drug Therapy, Combination
Endocarditis, Bacterial / drug therapy*,  microbiology
Female
Gentamicins / therapeutic use
Imipenem
Rats
Rats, Inbred Strains
Staphylococcal Infections / drug therapy*
Thienamycins / blood,  therapeutic use*
Time Factors
Chemical
Reg. No./Substance:
0/Gentamicins; 0/Thienamycins; 61-72-3/Cloxacillin; 74431-23-5/Imipenem

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Susceptibility of anaerobic bacteria to imipenem.
Next Document:  Imipenem therapy of Pseudomonas aeruginosa bacteraemia in neutropenic rats.